ArticleMolecular carcinogenesis2020

MYC-binding lncRNA EPIC1 promotes AKT-mTORC1 signaling and rapamycin resistance in breast and ovarian cancer.

Yifei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.